Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Health Behaviour Change

- PMLiVE

Life keeps on growing with appointment of Kirsty Mead

Windsor-based agency continues to expand its client service team with appointment of new account manager

- PMLiVE

Roche’s Perjeta on US fast-track for early breast cancer

FDA grants priority review for drug's use before surgery

- PMLiVE

The invisible customer

Find out why internal stakeholders are key to Pharma marketing success.

Blue Latitude Health

- PMLiVE

Spanish pharma recovery won’t begin until after 2014

Country's pharmaceutical market is yet to hit rock bottom

- PMLiVE

FDA forces Achillion to delay hepatitis C programme

Abnormal liver functions detected in some patients taking sovaprevir

- PMLiVE

Setback for Merck & Co as FDA knocks back insomnia drug

US regulator asks for company to file for approval of a lower starting dose of suvorexant

- PMLiVE

US increases pressure on India over generics industry

Follows complaints from Pfizer about the country’s patent laws

- PMLiVE

Icon promotes Brendan Buckley to chief medical officer

In his new role he will serve as the CRO's lead medical expert

- PMLiVE

Rebooting the innovation engine

How can the industry transform the efficacy of its R&D teams so they can do more with less?

- PMLiVE

GSK’s personalised cancer drug Tafinlar set for European approval

Regulatory advisors recommend the melanoma drug be licensed

- PMLiVE

Onyx rejects $10bn takeover bid from Amgen

Says offer is too low, but doesn't rule out a deal

- PMLiVE

First mAb biosimilars set for European approval

Celltrion and Hospira's versions of J&J's blockbuster Remicade recommended by CHMP

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links